BREMBATI, VIVIANA

BREMBATI, VIVIANA  

Dipartimento di Medicina Molecolare e Traslazionale  

Mostra records
Risultati 1 - 7 di 7 (tempo di esecuzione: 0.011 secondi).
Titolo Data di pubblicazione Autore(i) File
Alpha synuclein post translational modifications: potential targets for Parkinson’s disease therapy? 1-gen-2023 Brembati, V.; Faustini, G.; Longhena, F.; Bellucci, A.
An updated reappraisal of synapsins: structure, function and role in neurological and psychiatric disorders 1-gen-2021 Longhena, F.; Faustini, G.; Brembati, V.; Pizzi, M.; Benfenati, F.; Bellucci, A.
Changes in α-Synuclein Posttranslational Modifications in an AAV-Based Mouse Model of Parkinson's Disease 1-gen-2023 Brembati, Viviana; Faustini, Gaia; Longhena, Francesca; Outeiro, Tiago Fleming; Bellucci, Arianna
Dissecting the pathophysiology of alpha-synuclein and synapsin III interaction in conventional and patient-derived models of Parkinson’s disease 1-feb-2023 Brembati, Viviana
Methylphenidate Analogues as a New Class of Potential Disease-Modifying Agents for Parkinson’s Disease: Evidence from Cell Models and Alpha-Synuclein Transgenic Mice 1-gen-2022 Casiraghi, A.; Longhena, F.; Faustini, G.; Ribaudo, G.; Suigo, L.; Camacho-Hernandez, G. A.; Bono, F.; Brembati, V.; Newman, A. H.; Gianoncelli, A.; Straniero, V.; Bellucci, A.; Valoti, E.
Synapsin III gene silencing redeems alpha-synuclein transgenic mice from Parkinson's disease-like phenotype 1-gen-2022 Faustini, Gaia; Longhena, Francesca; Masato, Anna; Bassareo, Valentina; Frau, Roberto; Klingstedt, Therése; Shirani, Hamid; Brembati, Viviana; Parrella, Edoardo; Vezzoli, Marika; Nilsson, K Peter R; Pizzi, Marina; Spillantini, Maria Grazia; Bubacco, Luigi; Bellucci, Arianna
The good and bad of therapeutic strategies that directly target α-synuclein 1-gen-2019 Longhena, F.; Faustini, G.; Brembati, Viviana; Pizzi, M.; Bellucci, A.